CN107033051A - A kind of preparation method of ezetimibe - Google Patents

A kind of preparation method of ezetimibe Download PDF

Info

Publication number
CN107033051A
CN107033051A CN201710427949.3A CN201710427949A CN107033051A CN 107033051 A CN107033051 A CN 107033051A CN 201710427949 A CN201710427949 A CN 201710427949A CN 107033051 A CN107033051 A CN 107033051A
Authority
CN
China
Prior art keywords
ezetimibe
reactor
degrees celsius
solution
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710427949.3A
Other languages
Chinese (zh)
Inventor
彭凡
李娜
陈金利
何峰
叶志伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Lihe Biological Pharmaceutical Co Ltd
Original Assignee
Wuhan Lihe Biological Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Lihe Biological Pharmaceutical Co Ltd filed Critical Wuhan Lihe Biological Pharmaceutical Co Ltd
Priority to CN201710427949.3A priority Critical patent/CN107033051A/en
Publication of CN107033051A publication Critical patent/CN107033051A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)

Abstract

The invention discloses a kind of preparation method of ezetimibe, comprise the following steps:Dichloromethane is placed in reactor, and add ezetimibe ketone thereto in whipping process, it is to be mixed it is uniform after, add (R) 2 methyl CBS oxazaborolidines, and reacted in the presence of catalyst, then move into toluene solution, mixing processing is carried out to it by puddler, and it is slowly added dichloromethane solution thereto in whipping process, add mixed solution thereto again, highly basic will be inserted thereto to be washed, it is dried with anhydrous sodium sulfate, then filtering and crystallization, filtering, the acid-base property of crystal is detected using pH test paper, until its presentation is neutral, dry, produce ezetimibe.The reaction yield is high, and product purity is high, and cost is low, and avoids and use toxic agent, and the influence to environment is significantly reduced, and is suitable for large-scale industrial production.

Description

A kind of preparation method of ezetimibe
Technical field
The present invention relates to chemicals preparing technical field, more particularly to a kind of preparation method of ezetimibe.
Background technology
Ezetimibe is the new selective cholesterol absorption inhibitor of a class, by with intestinal brush border film vesicles Upper memebrane protein is combined, and suppresses the absorption that small intestine neutralizes the cholesterol being transported to through bile in enteron aisle to diet, reduction serum and liver Cholesterol level in dirty.Different from cholic acid intercalating agent, ezetimibe does not influence cholesteryl ester, other steroid (such as cow-bezoar courages Acid), the absorption of triacylglycerol and liposoluble vitamin.Its pharmacological action and acetyl coenzyme A-cholesterol acetyl transferase (ACAT) Suppression and ldl receptor (scavenger receptor) expression it is whether unrelated.Ezetimibe absorbed after in liver with glucose Through hepato-enteric circulation after aldehydic acid combination, small intestinal mucosa cell is almost specifically positioned at.Extensive, the road used with ezetimibe Form docking reaction yield is low in line, and intermediate need to be by post purifying, it is difficult to mass produced, existing preparation method Demand is can not meet, therefore, we have proposed a kind of preparation method of ezetimibe.
The content of the invention
The present invention proposes a kind of preparation method of ezetimibe, to solve the problems mentioned in the above background technology.
The present invention proposes a kind of preparation method of ezetimibe, comprises the following steps:
S1:It is raw material to choose ezetimibe -one, (R) -2- methyl-CBS- oxazaborolidines, dichloromethane solution, and according to for Rice shellfish -one, the molal weight ratio of (R) -2- methyl-CBS- oxazaborolidines are 3:1;
S2:Dichloromethane is placed in reactor, and the temperature in reactor is increased to 40-60 degrees Celsius, and is being stirred Add ezetimibe -one during mixing thereto, it is to be mixed it is uniform after, add (R) -2- methyl-CBS- oxazaborolidines, and Reacted in the presence of catalyst;
S3:Toluene solution is moved into the reactor stated then up again, and quickly cools the temperature to 12-18 degrees Celsius, Mixing processing is carried out to it by puddler, and dichloromethane solution is slowly added thereto in whipping process, is completed After addition, 8-10h is placed in stirring in the environment of 20-30 degrees Celsius;
S3:After reaction terminates, mixed solution is added thereto again, and stir under conditions of 40-50 degrees Celsius 20- It is layered after 40min, removes upper solution, highly basic will be inserted thereto and be washed;
S4:After the completion of above-mentioned, it is dried using anhydrous sodium sulfate, then filtering and crystallization, are completed after crystallization, then Secondary filtering;
S5:The acid-base property of crystal is detected using pH test paper, if crossing alkali or peracid, washing process is carried out to it, directly It is neutral to its presentation, dry, produce ezetimibe.
It is preferred that, the catalyst in S2 is tetraisopropyl titanate, ether, acetone or tetrahydrofuran.
It is preferred that, in above-mentioned, reactor before use, 10-13min need to be sterilized under conditions of 300-450 degrees Celsius, Then so that reactor is in sealing state.
It is preferred that, mixed solution in S3 is the mixture of methanol, sodium peroxide and sulfuric acid, and methanol, sodium peroxide Molal weight ratio with sulfuric acid is 3:2:0.5.
A kind of preparation method of ezetimibe proposed by the present invention, beneficial effect is:The preparation of the ezetimibe Method it is simple to operate easily-controllable, reaction yield is high, and product purity is high, and cost is low, and avoids and use toxic agent, to environment Influence is significantly reduced, and is suitable for large-scale industrial production.
Embodiment
With reference to specific embodiment, the present invention will be further described.
Embodiment 1
The present invention proposes a kind of preparation method of ezetimibe, comprises the following steps:
S1:It is raw material to choose ezetimibe -one, (R) -2- methyl-CBS- oxazaborolidines, dichloromethane solution, and according to for Rice shellfish -one, the molal weight ratio of (R) -2- methyl-CBS- oxazaborolidines are 3:1;
S2:Dichloromethane is placed in reactor, and the temperature in reactor is increased to 40 degrees Celsius, and stirred Add ezetimibe -one in journey thereto, it is to be mixed it is uniform after, add (R) -2- methyl-CBS- oxazaborolidines, and in catalysis Reacted in the presence of agent;
S3:Toluene solution is moved into the reactor stated then up again, and quickly cools the temperature to 12 degrees Celsius, is passed through Puddler carries out mixing processing to it, and is slowly added dichloromethane solution thereto in whipping process, completes addition Afterwards, 8h is placed in stirring in the environment of 20 degrees Celsius;
S3:After reaction terminates, mixed solution is added thereto again, and after stirring 20min under conditions of 40 degrees Celsius It is layered, removes upper solution, highly basic will be inserted thereto and be washed;
S4:After the completion of above-mentioned, it is dried using anhydrous sodium sulfate, then filtering and crystallization, are completed after crystallization, then Secondary filtering;
S5:The acid-base property of crystal is detected using pH test paper, if crossing alkali or peracid, washing process is carried out to it, directly It is neutral to its presentation, dry, produce ezetimibe.
Catalyst in S2 is tetraisopropyl titanate, ether, acetone or tetrahydrofuran.
In above-mentioned, reactor is before use, 10min need to be sterilized under conditions of 300 degrees Celsius, then so that reactor In sealing state.
Mixed solution in S3 is the mixture of methanol, sodium peroxide and sulfuric acid, and methanol, sodium peroxide and sulfuric acid Molal weight ratio is 3:2:0.5.
Embodiment 2
The present invention proposes a kind of preparation method of ezetimibe, comprises the following steps:
S1:It is raw material to choose ezetimibe -one, (R) -2- methyl-CBS- oxazaborolidines, dichloromethane solution, and according to for Rice shellfish -one, the molal weight ratio of (R) -2- methyl-CBS- oxazaborolidines are 3:1;
S2:Dichloromethane is placed in reactor, and the temperature in reactor is increased to 45 degrees Celsius, and stirred Add ezetimibe -one in journey thereto, it is to be mixed it is uniform after, add (R) -2- methyl-CBS- oxazaborolidines, and in catalysis Reacted in the presence of agent;
S3:Toluene solution is moved into the reactor stated then up again, and quickly cools the temperature to 14 degrees Celsius, is passed through Puddler carries out mixing processing to it, and is slowly added dichloromethane solution thereto in whipping process, completes addition Afterwards, 8.5h is placed in stirring in the environment of 24 degrees Celsius;
S3:After reaction terminates, mixed solution is added thereto again, and after stirring 25min under conditions of 44 degrees Celsius It is layered, removes upper solution, highly basic will be inserted thereto and be washed;
S4:After the completion of above-mentioned, it is dried using anhydrous sodium sulfate, then filtering and crystallization, are completed after crystallization, then Secondary filtering;
S5:The acid-base property of crystal is detected using pH test paper, if crossing alkali or peracid, washing process is carried out to it, directly It is neutral to its presentation, dry, produce ezetimibe.
Catalyst in S2 is tetraisopropyl titanate, ether, acetone or tetrahydrofuran.
In above-mentioned, reactor is before use, 11min need to be sterilized under conditions of 350 degrees Celsius, then so that reactor In sealing state.
Mixed solution in S3 is the mixture of methanol, sodium peroxide and sulfuric acid, and methanol, sodium peroxide and sulfuric acid Molal weight ratio is 3:2:0.5.
Embodiment 3
The present invention proposes a kind of preparation method of ezetimibe, comprises the following steps:
S1:It is raw material to choose ezetimibe -one, (R) -2- methyl-CBS- oxazaborolidines, dichloromethane solution, and according to for Rice shellfish -one, the molal weight ratio of (R) -2- methyl-CBS- oxazaborolidines are 3:1;
S2:Dichloromethane is placed in reactor, and the temperature in reactor is increased to 55 degrees Celsius, and stirred Add ezetimibe -one in journey thereto, it is to be mixed it is uniform after, add (R) -2- methyl-CBS- oxazaborolidines, and in catalysis Reacted in the presence of agent;
S3:Toluene solution is moved into the reactor stated then up again, and quickly cools the temperature to 16 degrees Celsius, is passed through Puddler carries out mixing processing to it, and is slowly added dichloromethane solution thereto in whipping process, completes addition Afterwards, 9h is placed in stirring in the environment of 28 degrees Celsius;
S3:After reaction terminates, mixed solution is added thereto again, and after stirring 30min under conditions of 48 degrees Celsius It is layered, removes upper solution, highly basic will be inserted thereto and be washed;
S4:After the completion of above-mentioned, it is dried using anhydrous sodium sulfate, then filtering and crystallization, are completed after crystallization, then Secondary filtering;
S5:The acid-base property of crystal is detected using pH test paper, if crossing alkali or peracid, washing process is carried out to it, directly It is neutral to its presentation, dry, produce ezetimibe.
Catalyst in S2 is tetraisopropyl titanate, ether, acetone or tetrahydrofuran.
In above-mentioned, reactor is before use, 12min need to be sterilized under conditions of 400 degrees Celsius, then so that reactor In sealing state.
Mixed solution in S3 is the mixture of methanol, sodium peroxide and sulfuric acid, and methanol, sodium peroxide and sulfuric acid Molal weight ratio is 3:2:0.5.
Embodiment 4
The present invention proposes a kind of preparation method of ezetimibe, comprises the following steps:
S1:It is raw material to choose ezetimibe -one, (R) -2- methyl-CBS- oxazaborolidines, dichloromethane solution, and according to for Rice shellfish -one, the molal weight ratio of (R) -2- methyl-CBS- oxazaborolidines are 3:1;
S2:Dichloromethane is placed in reactor, and the temperature in reactor is increased to 60 degrees Celsius, and stirred Add ezetimibe -one in journey thereto, it is to be mixed it is uniform after, add (R) -2- methyl-CBS- oxazaborolidines, and in catalysis Reacted in the presence of agent;
S3:Toluene solution is moved into the reactor stated then up again, and quickly cools the temperature to 18 degrees Celsius, is passed through Puddler carries out mixing processing to it, and is slowly added dichloromethane solution thereto in whipping process, completes addition Afterwards, 10h is placed in stirring in the environment of 30 degrees Celsius;
S3:After reaction terminates, mixed solution is added thereto again, and after stirring 40min under conditions of 50 degrees Celsius It is layered, removes upper solution, highly basic will be inserted thereto and be washed;
S4:After the completion of above-mentioned, it is dried using anhydrous sodium sulfate, then filtering and crystallization, are completed after crystallization, then Secondary filtering;
S5:The acid-base property of crystal is detected using pH test paper, if crossing alkali or peracid, washing process is carried out to it, directly It is neutral to its presentation, dry, produce ezetimibe.
Catalyst in S2 is tetraisopropyl titanate, ether, acetone or tetrahydrofuran.
In above-mentioned, reactor is before use, 13min need to be sterilized under conditions of 450 degrees Celsius, then so that reactor In sealing state.
Mixed solution in S3 is the mixture of methanol, sodium peroxide and sulfuric acid, and methanol, sodium peroxide and sulfuric acid Molal weight ratio is 3:2:0.5.
The foregoing is only a preferred embodiment of the present invention, but protection scope of the present invention be not limited thereto, Any one skilled in the art the invention discloses technical scope in, technique according to the invention scheme and its Inventive concept is subject to equivalent substitution or change, should all be included within the scope of the present invention.

Claims (4)

1. a kind of preparation method of ezetimibe, it is characterised in that comprise the following steps:
S1:Ezetimibe -one, (R) -2- methyl-CBS- oxazaborolidines, dichloromethane solution are chosen for raw material, and ezetimibe - Ketone, the molal weight ratio of (R) -2- methyl-CBS- oxazaborolidines are 3:1;
S2:Dichloromethane is placed in reactor, and the temperature in reactor is increased to 40-60 degrees Celsius, and stirred Add ezetimibe -one in journey thereto, it is to be mixed it is uniform after, add (R) -2- methyl-CBS- oxazaborolidines, and in catalysis Reacted in the presence of agent;
S3:Toluene solution is moved into the reactor stated then up again, and quickly cools the temperature to 12-18 degrees Celsius, is passed through Puddler carries out mixing processing to it, and is slowly added dichloromethane solution thereto in whipping process, completes addition Afterwards, 8-10h is placed in stirring in the environment of 20-30 degrees Celsius;
S3:After reaction terminates, mixed solution is added thereto again, and stir under conditions of 40-50 degrees Celsius 20-40min It is layered afterwards, removes upper solution, highly basic will be inserted thereto and be washed;
S4:After the completion of above-mentioned, it is dried using anhydrous sodium sulfate, then filtering and crystallization, are completed after crystallization, again mistake Filter;
S5:The acid-base property of crystal is detected using pH test paper, if crossing alkali or peracid, washing process is carried out to it, until its It is presented neutral, dries, produce ezetimibe.
2. a kind of preparation method of ezetimibe according to claim 1, it is characterised in that:Catalyst in S2 is Tetraisopropyl titanate, ether, acetone or tetrahydrofuran.
3. a kind of preparation method of ezetimibe according to claim 1, it is characterised in that:In above-mentioned, reactor Before use, 10-13min need to be sterilized under conditions of 300-450 degrees Celsius, then so that reactor is in sealing state.
4. a kind of preparation method of ezetimibe according to claim 1, it is characterised in that:Mixed solution in S3 It is 3 for the molal weight ratio of the mixture of methanol, sodium peroxide and sulfuric acid, and methanol, sodium peroxide and sulfuric acid:2:0.5.
CN201710427949.3A 2017-06-08 2017-06-08 A kind of preparation method of ezetimibe Pending CN107033051A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710427949.3A CN107033051A (en) 2017-06-08 2017-06-08 A kind of preparation method of ezetimibe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710427949.3A CN107033051A (en) 2017-06-08 2017-06-08 A kind of preparation method of ezetimibe

Publications (1)

Publication Number Publication Date
CN107033051A true CN107033051A (en) 2017-08-11

Family

ID=59541977

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710427949.3A Pending CN107033051A (en) 2017-06-08 2017-06-08 A kind of preparation method of ezetimibe

Country Status (1)

Country Link
CN (1) CN107033051A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045406A1 (en) * 1996-05-31 1997-12-04 Schering Corporation 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045406A1 (en) * 1996-05-31 1997-12-04 Schering Corporation 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GUANGZHONG WU等: "A Novel One-Step Diastereo- and Enantioselective Formation of", 《J.ORG.CHEM》 *

Similar Documents

Publication Publication Date Title
CA1184897A (en) Process for the separation of sterols or mixtures of sterols
CN108558636A (en) A kind of preparation method of 4- bromobenzoic acids
CN106699831B (en) A method of liquid crystal cholesterol is prepared using lanolin using complexometry
CN108794557A (en) A kind of preparation method of chenodeoxycholic acid and intermediate
CN104892623A (en) Preparation method for isosorbide 5-mononitrate
CN107033051A (en) A kind of preparation method of ezetimibe
CN105622696B (en) Method for purifying dehydroepiandrosterone by emulsifying leaching process
CN108299540A (en) A kind of synthetic method of Tauro ursodesoxy cholic acid
CN108586206A (en) One kettle way prepares 4,4 '-butylidenebis(6- tertiary butyl metacresols)Method
CN103665078B (en) A kind of preparation method of 17 Alpha-hydroxy steroidal esters
CN101812107B (en) Method for synthesizing clobetasol propionate intermediate
CN107501374A (en) A kind of method that dehydroepiandros-sterone is reclaimed in the mother liquor thing from dehydroepiandros-sterone
CN106866677A (en) The purifying of Ticagrelor and preparation method
CN108997464A (en) A kind of processing method of testosterone mother liquor object
CN106831923A (en) A kind of preparation method of chenodeoxycholic acid
CN105315244A (en) Preparation method of L-ascorbic acid-6-palmitate
PL81228B1 (en)
CN107365341A (en) The preparation method of flurogestone acetate
CN105753747B (en) A kind of industrialized production new method for preparing high-purity docusate sodium PEG solution
CN104356187B (en) Method for recycling hydrocortisone in hydrocortisone butyrate mother liquor
CN110127640A (en) The method and apparatus for refining hydroxylamine hydrochloride product
CN108554340A (en) A kind of hydrogen fluoride ammonia process units
CN103121960B (en) Efficient recrystallization method of tetraacetylethylenediamine
CN109734765B (en) Preparation method of 17 a-dehydroxyacetic acid prednisolone product
CN104031003A (en) Complex solvent refining method of MBT (2-mercaptobenzothiazole)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170811